Favorites and recent references stay on this device. No patient data is stored.
Choose the species
One selection filters the source overview, clinical facts, reports and dose calculator. Literature references are not species-filtered.
Choose one species for its overview and dose calculator, or all species to browse the full evidence.
Source overview
Recorded excerpts for one species. Each dose remains a separate source entry; no regimen is selected.
No clinical assertions recorded for an overview.
View full clinical evidence and sources ↓Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects178
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Deafness94 reports
- Partial deafness68 reports
- Lack of efficacy - NOS56 reports
- Vomiting51 reports
- Diarrhoea30 reports
- Anorexia20 reports
- Lethargy (see also Central nervous system depression in 'Neurological')20 reports
- Lethargy (see also Central nervous system depression in Neurological)20 reports
- Other abnormal test result NOS20 reports
- Ear infection NOS17 reports
- Emesis17 reports
- Ataxia14 reports
Cat
- Anorexia6 reports
- Depression6 reports
- Polydipsia4 reports
- Behavioural disorder NOS3 reports
- Eye disorder NOS (for photophobia see 'neurological')3 reports
- Weight loss3 reports
- Blindness2 reports
- Deafness2 reports
- Diarrhoea2 reports
- Ear discharge2 reports
- Fever2 reports
- Hypersalivation2 reports
Literature references12
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Overcoming corneal barriers: Posaconazole loaded cationic surfactant vesicles for enhanced ocular permeability and anti-fungal efficacy.
Study summary not available in the imported record. Open the original citation to review the study.
- Unlocking the Unreachable: Cationic ThermoSomes for Next-Generation Posaconazole Therapy.
Study summary not available in the imported record. Open the original citation to review the study.
- Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort.
Study summary not available in the imported record. Open the original citation to review the study.
- Synergistic potential of lopinavir and azole combinational therapy against clinically important Aspergillus species.
Study summary not available in the imported record. Open the original citation to review the study.
- Extracellular phospholipase production by Malassezia pachydermatis strains and its inhibition by selected antimycotics and plant essential oil components.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.
Available products
Products listed in the Health Canada Drug Product Database for this active ingredient. A listing does not establish that a product is authorized for the clinical uses described on this page.